Paid Stock Options Subject to Cumulative Operating Profit
First written in FY2016. 1 of 23 entries say "Advanced", first in FY2017-Q1. Latest entry: FY2025-H1.
The whole theme swung hardest in 2020: 2 of 16 companies on the "Worse" side.
12 other companies' latest entry also says "Other".
- FY2025-H1Increase in shares through the exercise of stock acquisition rightsAnnual report
「1 April 2024–30 September 2024 63,600 26,328,700 * Increase due to the exercise of stock acquisition rights.」
Common shares increased by 63,600 during the interim period through the exercise of stock acquisition rights, describing developments following the continued exercise of the Series 6 Stock Acquisition Rights. - FY2024Continued exercise of Series 6 Stock Acquisition RightsAnnual report
「End of previous fiscal year 210,000 Vested － Exercised 6,000 Expired － Remaining unexercised 204,000」
6,000 shares under the Series 6 Stock Acquisition Rights were exercised during the period, leaving 204,000 shares unexercised at the end of the period. The exercise period runs through 30 June 2024. - FY2024-Q1Continued exercise of Series 6 Stock Acquisition RightsAnnual report
「1 April 2023–30 June 2023 (Note) 6,000 26,265,100 201 44,402 201 402 (Note) Increase due to the exercise of stock acquisition rights.」
From April through June 2023, common shares increased by 6,000 through the exercise of stock acquisition rights, confirming the continued exercise of the Series 6 Stock Acquisition Rights. - FY2023Continued exercise of Series 6 Stock Acquisition RightsAnnual report
「The stock options outstanding during the consolidated fiscal year ended March 2023 are covered, and the number of stock options is stated in terms of shares. Series 6 Stock Acquisition Rights: 6,000 shares exercised; 210,000 shares remaining unexercised」
6,000 shares under the Series 6 Stock Acquisition Rights were exercised in the fiscal year ended March 2023, leaving 210,000 shares unexercised at the end of the period. - FY2022-Q2AchievedAnnual report
「During the second-quarter accounting period, these stock acquisition rights were exercised as follows.」
During the second quarter, 33,220 Series 10 Stock Acquisition Rights were exercised, raising ¥353.263 million through the issuance of 3,322,000 shares. All Series 9 Stock Acquisition Rights were exercised on 7 May 2021, and all Series 10 Stock Acquisition Rights on 24 September 2021, after which both series lapsed. - FY2022-Q1Exercise of Series 9 and Series 10 Stock Acquisition Rights is progressingAnnual report
「Series 9 Stock Acquisition Rights: number of the applicable stock acquisition rights with exercise-price adjustment conditions exercised during the quarter (units), 4,200 units; number of shares issued upon exercise during the quarter (shares), 420,000 shares. Series 10 Stock Acquisition Rights: 16,780 units; 1,678,000 shares」
During the first quarter, 420,000 shares under the Series 9 Stock Acquisition Rights and 1,678,000 shares under the Series 10 Stock Acquisition Rights were issued upon exercise, and financing progressed. - FY2021Full exercise and lapse of all Series 8 Stock Acquisition RightsAnnual report
「All Series 8 Stock Acquisition Rights were fully exercised and lapsed on 2 February 2021.」
All Series 8 Stock Acquisition Rights were fully exercised, involving the issuance of a cumulative 2,500,000 shares, and then lapsed. A further 2,080,000 shares under the Series 9 Stock Acquisition Rights were exercised during the period. - FY2021-Q2Continued exercise of stock acquisition rightsAnnual report
「1 July 2020–30 September 2020 (Note) 1 3,600 10,730,400」
Common shares increased by 3,600 during the second-quarter accounting period through the exercise of stock acquisition rights, followed by a further increase of 2,400 shares by the filing date. - FY2020Continued exercise of stock acquisition rightsAnnual report
「1 April 2019–31 March 2020 Common shares 282,000」
Common shares increased by 282,000 during the period through the exercise of stock acquisition rights, and exercises of stock options, including performance-based options, continued. - FY2020-Q3Continued exercise of stock acquisition rightsAnnual report
「1 October 2019–31 December 2019 (Note) 1 30,000 10,698,000 1,005 263,288 1,005 221,300 (Note) 1. Increase due to the exercise of stock acquisition rights.」
Common shares increased by 30,000 during the third-quarter accounting period through the exercise of stock acquisition rights, and a further increase of 6,000 shares was reported in January 2020. - FY2020-Q2Continued exercise of stock acquisition rightsAnnual report
「Change in total number of issued shares 196,800 10,668,000 (Note) 1. Increase due to the exercise of stock acquisition rights.」
Common shares increased by 196,800 through the exercise of stock acquisition rights from July to September 2019, and exercises continued. - FY2020-Q1Continued exercise of stock acquisition rightsAnnual report
「1 April 2019–30 June 2019 38,400 10,471,200」
Common shares increased by 38,400 in the first quarter through the exercise of stock acquisition rights, and exercises of stock acquisition rights, including performance-based stock acquisition rights, continued. - FY2019Stock acquisition rights lapsed because the exercise conditions were not metAnnual report
「All of the Series 7 Stock Acquisition Rights lapsed as of 22 May 2019 because the exercise conditions for the stock acquisition rights described in 3 above were no longer met.」
All Series 7 Stock Acquisition Rights subject to cumulative operating profit of ¥2 billion and ¥2.2 billion lapsed on 22 May 2019 because the exercise conditions were not met. Meanwhile, 186,000 shares were issued during the period through the exercise of the Series 6 Stock Acquisition Rights. - FY2019-Q3Continued exercise of stock acquisition rightsAnnual report
「1 October 2018–31 December 2018 (Note) 1 62,400 10,371,600 2,121 253,863 2,059 211,915」
Common shares increased by 62,400 during the third-quarter accounting period through the exercise of stock acquisition rights, and exercises continued. - FY2019-Q2Continued exercise of stock acquisition rightsAnnual report
「1 July 2018–30 September 2018 (Note) 1 21,600 10,309,200 (Note) 1. Increase due to the exercise of stock acquisition rights.」
Common shares increased by 21,600 during the second-quarter accounting period through the exercise of stock acquisition rights, bringing the number of issued shares as of the filing date to 10,323,600. - FY2019-Q1Continued exercise of stock acquisition rightsAnnual report
「The increase in common shares from the end of the first quarter accounting period through the date of filing was attributable to the exercise of stock acquisition rights.」
Common shares increased by 40,800 during the first quarter through the exercise of stock acquisition rights, and increased by a further 2,400 shares in July 2018. - FY2018Continued exercise of stock acquisition rightsAnnual report
「15 May 2017–31 March 2018 Common shares 423,600」
423,600 shares were issued during the period through the exercise of stock acquisition rights, including performance-based stock acquisition rights. - FY2018-Q3Continued exercise of stock acquisition rightsAnnual report
「1 October 2017–31 December 2017 (Note) 1 124,800 10,142,400 4,243 246,071 4,118 204,351」
Common shares increased by 124,800 during the third-quarter accounting period through the exercise of stock acquisition rights. A further increase of 24,000 shares was reported in January 2018, indicating that exercises continued. - FY2018-Q2Continued exercise of stock acquisition rightsAnnual report
「The increase in common shares from the end of the second quarter accounting period to the filing date was due to the exercise of stock acquisition rights.」
From July through September 2017, 67,200 shares were issued through the exercise of stock acquisition rights, and a further increase of 8,400 shares was reported in October. - FY2018-Q1Exercise of stock acquisition rights is progressingAnnual report
「1 April 2017–30 June 2017 (Note) 1 127,200 9,950,400 4,324 239,543 4,197 198,015」
This was not a change to the scheme itself, which is subject to cumulative operating profit, but 127,200 shares were issued in the first quarter through the exercise of stock acquisition rights, and a further increase of 54,000 shares was reported in July. - FY2017RestatedAnnual report
「If the total operating profit for the 3 fiscal years from the fiscal year ended March 2017 through the fiscal year ended March 2019, as stated in the consolidated statements of income included in the annual securities report filed by the company under the Financial Instruments and Exchange Act, or in the statements of income if consolidated financial statements are not prepared, hereinafter referred to as cumulative operating profit, meets any of the following conditions, the holders may exercise the allocated stock acquisition rights up to the percentage specified for that condition.」
Reiterates the framework for performance-based stock options subject to cumulative operating profit of ¥2 billion and ¥2.2 billion for the fiscal years ended March 2017 through March 2019. - FY2017-Q1AdvancedAnnual report
「At a meeting of the Board of Directors held on 24 June 2016, the company resolved, pursuant to Articles 236, 238 and 240 of the Companies Act, to issue performance-based subscription stock acquisition rights (paid stock options) to the company's directors, excluding outside directors, and employees. These stock acquisition rights were issued on 11 July 2016 as set out below.」
Following the Board of Directors' resolution, 1,600 paid stock options representing 160,000 shares, subject to cumulative operating profit exercise conditions of ¥2 billion and ¥2.2 billion, were issued on 11 July 2016. - FY2016First statedAnnual report
「If the total operating profit for the 3 fiscal years from the fiscal year ended March 2017 through the fiscal year ended March 2019, hereinafter referred to as cumulative operating profit, meets any of the following conditions, the holders may exercise the allocated stock acquisition rights up to the percentage specified for that condition: (a) if cumulative operating profit for the 3 fiscal years exceeds ¥2 billion: 50%; (b) if cumulative operating profit for the 3 fiscal years exceeds ¥2.2 billion: 100%.」
Performance-linked incentives subject to cumulative operating profit targets of ¥2 billion and ¥2.2 billion for the fiscal years from the fiscal year ended March 2017 through the fiscal year ended March 2019.